Importantly, several CCR1 antagonists, such as MLN3897 for rheumatoid arthritis [220], BX471 for multiple sclerosis [220], and BAY86-5047 for endometriosis [221], are under investigation in clinical studies. This evidence concerns the gene CCR1 and rheumatoid arthritis.